Results 231 to 240 of about 2,984,719 (362)

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Adhesion strength of tumor cells predicts metastatic disease in vivo. [PDF]

Cell Rep
Kane MA, Birmingham KG, Yeoman B, Patel N, Sperinde H, Molley TG, Beri P, Tuler J, Kumar A, Klein S, Zare S, Wallace A, Katira P, Engler AJ.   +13 more
europepmc   +1 more source

Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor.

, 1954
W Umiker, Lalla Iverson
openalex  

Morphological Studies on Human Ascites Tumor Cells by Tissue culture

, 1959
Takakazu Asaka
openalex   +2 more sources

The effectiveness of small amounts of preoperative irradiation in preventing the growth of tumor cells disseminated at surgery.An experimental study [PDF]

, 1961
Robert C. Hoye, Robert R. Smith
openalex   +1 more source

Multiple isoaccepting transfer RNA's in a muouse plasma cell tumor. [PDF]

, 1968
W K Yang, G. David Novelli
openalex   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment. [PDF]

Mol Cancer
Xiao G, Wang X, Xu Z, Liu Y, Jing J.
europepmc   +1 more source

Ultrastructural features of functioning alpha- and beta-cell tumors [PDF]

, 1969
Victor E. Goldenberg, N. S. Goldenberg, Earl P. Benditt   +2 more
openalex   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source